Horny Goat Weed
Horny goat weed (Epimedium) has no credible human trials for erectile dysfunction — the entire premise is in-vitro PDE5 inhibition by icariin that is orders of magnitude weaker than sildenafil. Its only decent randomized data are for bone loss, and this category is a hotspot for products spiked with prescription ED drugs.
What the science says
- Improves erectile dysfunction Limited evidence
Icariin does inhibit phosphodiesterase-5 in vitro, but at roughly 80-fold lower potency than sildenafil, and oral bioavailability is poor. There are no adequately designed, placebo-controlled human trials of Epimedium for erectile function using validated instruments such as the IIEF. Every claim here is extrapolated from cell and rodent work.
- Prevents postmenopausal bone loss Limited evidence
A 24-month randomized, double-blind, placebo-controlled trial in late postmenopausal women found Epimedium-derived flavonoids (60 mg icariin plus small amounts of daidzein and genistein daily) significantly slowed bone mineral density loss at the femoral neck and lumbar spine versus placebo. This is a single trial of a specific combination product with no fracture endpoints, and it has not been replicated — it does not make Epimedium a bone therapy.
- Delivers meaningful icariin exposure from standard supplements Limited evidence
A randomized, double-blind, placebo-controlled trial in postmenopausal women characterizing Epimedium prenylflavonoid pharmacokinetics and effects on bone-specific alkaline phosphatase and the osteoclast adaptor TRAF6 found the extract was tolerated but did not demonstrate the clear bone-turnover changes the mechanism predicts. Absorption of prenylflavonoids is variable and heavily dependent on preparation, so "10% icariin" on a label tells you little about what reaches the bloodstream.
- Raises testosterone Limited evidence
No human trial has shown Epimedium raises testosterone. The claim comes from the folk name and from animal studies at doses that do not translate.
Dosage & safety
Scientific references
- Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial
- Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women
Where to buy
NOW Foods, Horny Goat Weed Extract, 90 Tablets
View on iHerbReferral link — this site may earn a commission on purchases.
Related in Men's health
- D-Aspartic Acid Limited evidence
- Tribulus Terrestris Limited evidence
- Tongkat Ali Moderate evidence
- Maca Root Limited evidence
- Yohimbine Moderate evidence
- Stinging Nettle Limited evidence